News

@supplyht
supplyht. com > articles > 107162-from-reporting-to-serving

From reporting to serving

1+ hour, 5+ min ago  (605+ words) In mid-March, I marked six years as Chief Editor of Supply House Times. March 16, to be exact. I'll never forget my first day on the job in 2020. Headlines from that day included: "White House issues "15 Days to Slow the Spread…...

open PR. com
openpr. com > news > 4464487 > biomedical-crispr-gene-editing-market-set-to-boom-rapidly

Biomedical Crispr Gene Editing Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | " CRISPR Therapeutics " Intellia Therapeutics " Caribou Biosciences

51+ min ago  (76+ words) Biomedical Crispr Gene Editing Market Set to Boom Rapidly, open PR. com Biomedical Crispr Gene Editing Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | " CRISPR Therapeutics " Intellia Therapeutics " Caribou Biosciences Press release from: Coherent Market Insights Pvt. Ltd. Permanent…...

open PR. com
openpr. com > news > 4464485 > medication-safety-information-services-market-is-going-to-boom

Medication Safety Information Services Market Is Going to Boom |

53+ min ago  (50+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

open PR. com
openpr. com > news > 4463913 > global-drivers-analysis-the-rapid-evolution-of-the-clinical

Global Drivers Analysis: The Rapid Evolution of the Clinical Trial Platform Market

3+ hour, 59+ min ago  (59+ words) open PR. com Global Drivers Analysis: The Rapid Evolution of the Clinical Trial Platform Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Global Drivers Analysis: The…...

open PR. com
openpr. com > news > 4463957 > leading-companies-fueling-growth-and-innovation-in-the-clinical

Leading Companies Fueling Growth and Innovation in the Clinical Trial Support Services Market

3+ hour, 48+ min ago  (62+ words) open PR. com Leading Companies Fueling Growth and Innovation in the Clinical Trial Support Services Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Leading Companies Fueling…...

open PR. com
openpr. com > news > 4463941 > leading-companies-enhancing-their-roles-in-the-cell-and-gene

Leading Companies Enhancing Their Roles in the Cell and Gene Therapy Supply Chain and Logistics Market

3+ hour, 51+ min ago  (79+ words) open PR. com Leading Companies Enhancing Their Roles in the Cell and Gene Therapy Supply Chain and Logistics Market Press release from: The Business Research Company Cell And Gene Therapy Supply Chain/Logistics Market Permanent link to this press release:…...

Investing. com
investing. com > news > company-news > verastems-cancer-drug-combo-shows-durability-in-2year-data-93 CH-4607512

Verastem's cancer drug combo shows durability in 2-year data By Investing. com

1+ hour ago  (297+ words) European defense stocks tumble, construction gains on Ukraine peace deal talk Iran says no delegation sent to Pakistan, talks still suspended - state media Fragile U. S. -Iran ceasefire in focus; CPI ahead - what's moving markets A rare S&P 500 gap-up on Wednesday:…...

이데일리
edaily. co. kr > News > Read

SCD Pharm's Taiwan patent not a gateway to major market approvals" [K-Bio Pulse]

13+ hour, 4+ min ago  (21+ words) " 2026-04-10 " 8: 01: 03 " 2026-04-10 " 8: 01: 03 " " "by Dable " " " " MICE " " The Be LT " " " "+ '" "' " " " " "-" " " " NEXTECH " " " " "...

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > annovis-announces-10-million-underwritten-123000679. html

Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants

19+ hour, 35+ min ago  (594+ words) MALVERN, Pa. , April 09, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (Annovis" or the Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the…...

Minichart
minichart. com. sg > 04/10/2026 > annovis-bio-announces-10-million-underwritten-offering-to-advance-alzheimers-and-parkinsons-drug-development

Annovis Bio Announces $10 Million Underwritten Offering to Advance Alzheimer's and Parkinson's Drug Development

1+ hour, 5+ min ago  (258+ words) Minichart Annovis Bio Announces $10 Million Underwritten Offering to Advance Alzheimer's and Parkinson's Drug Development Annovis Bio Announces \$10 Million Underwritten Offering of Common Stock and Warrants Date: April 9, 2026 Key Points for Investors - Offering Details: Annovis Bio, Inc. (NYSE: ANVS) has announced…...